Detecting Necroptosis in Virus-Infected Cells

Samantha M Cotsmire1, Mateusz Szczerba1, Bertram L Jacobs2

  • 1Center for Immunotherapy, Vaccines and Virotherapy, Biodesign Institute, Arizona State University, Tempe, AZ, USA.

Insights

Necroptosis, a cell death pathway involving MLKL, is crucial in diseases like cancer and Alzheimer's. This study details methods to identify necroptosis by quantifying cell death and analyzing MLKL activation.

Area of Science:

  • Cellular biology
  • Molecular mechanisms of disease
  • Biochemistry

Background:

  • Necroptosis is a critical cell death pathway implicated in various human diseases, including cancers, neurodegenerative disorders like Alzheimer's, and viral infections.
  • The cell death process involves the mixed-lineage kinase domain-like protein (MLKL), which, upon activation, forms pores in the cytoplasmic membrane, leading to cellular lysis.

Purpose of the Study:

  • To address the need for optimized methods to identify and study necroptosis.
  • To describe novel approaches for detecting necroptosis and its molecular underpinnings.

Main Methods:

  • Quantifying cell death using specific pathway inhibitors to confirm necroptosis.
  • Employing western blots to detect key molecular events, including MLKL activation.
  • Investigating protein-protein interactions crucial for initiating the necroptosis cascade.

Main Results:

  • Successful identification of necroptosis through a combination of cell death assays and molecular analyses.
  • Demonstration of MLKL activation as a reliable indicator of necroptosis.
  • Characterization of protein interactions involved in the necroptosis pathway.

Conclusions:

  • The described methods provide a robust framework for identifying and studying necroptosis.
  • Accurate identification of necroptosis is essential for understanding its role in disease pathogenesis.
  • Further development of these techniques will aid in therapeutic strategies targeting necroptosis.